Our role as a catalytic investor
We don’t just fund projects—we drive meaningful change in markets. We strategically deploy patient, risk-tolerant investments to fill critical gaps where timely, catalytic capital can unlock outsized impact. Our $20M in investments into impact funds has mobilized $290M in additional capital, creating a significant multiplier effect for global health innovation.
Our strategic investments in three groundbreaking impact venture funds demonstrate our commitment to reshaping health finance:
Global Health Investment Fund
As an anchor investor in this $108M innovative equity fund in 2012, GCC helped validate a new model for global health investing. GHIF portfolio companies develop new or improved drugs, vaccines and diagnostics against diseases that disproportionately burden people in low- and middle-income countries and have delivered impressive results:
- Reaching over 250 million people across low- and middle-income countries
- Generating 2x returns ($255M in realized projects on $98M deployed)
- Inspiring $1B in additional funds for global health impact investing
One standout example amongst many is Eubiologics, a company which has delivered over 130M cholera vaccine doses to 25 countries, becoming the only global manufacturer with WHO prequalification.
Cross-Border Impact Ventures
GCC incubated this $90M USD equity fund, the first of its kind dedicated to women’s and children’s health technologies that serve dual markets in the Global North and Global South. Structured with a blended capital stack and led by two first-time Canadian women fund managers, CBIV is projected to:
- Reach 9-15 million women, children, and adolescents in low- and middle-income countries
- Improve the lives of 6-12 million people
Launched in 2021, CBIV has already achieved its first exit with Sonio, an AI software company improving prenatal care, which was acquired by Samsung Medison in 2024, less than a year after investment.
Transform Health Fund
Our $5M USD investment represented over 25% of the catalytic capital pool in the first close of this $111M USD debt fund designed with a blended finance structure consisting of commercial and catalytic layers of investment. Transform Health Fund (THF) uniquely focuses exclusively on supporting African healthcare companies and aims to:
- Reach 15 million people, with over 50% being women
- Create over 15,000 new jobs, with gender equity as a priority
- Deploy $175M after recycling of capital
